CHINOOK THERAPEUTICS XXX
COM · CUSIP 169CVR016
4
institutional holders
-1 vs Q1 2025
168.1k
shares reported held*
$2.5kreported value*
0 new
0 added
2 reduced
1 sold out
net sold ≈ $7.8k (-307.8k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.01.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2023 | 2 |
| Q4 2023 | 4 |
| Q1 2024 | 4 |
| Q2 2024 | 4 |
| Q3 2024 | 4 |
| Q4 2024 | 6 |
| Q1 2025 | 5 |
| Q2 2025 | 4 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 1 | 0 |
| Q1 2024 | 0 | 0 |
| Q2 2024 | 0 | 1 |
| Q3 2024 | 0 | 1 |
| Q4 2024 | 3 | 0 |
| Q1 2025 | 1 | 3 |
| Q2 2025 | 0 | 3 |
Biggest buyers
| None |
Biggest sellers
| Erste Asset Management GmbH | Sold out | -307.8k |
| Sterling Capital Management LLC | Reduced | -47 |
| RHUMBLINE ADVISERS | Reduced | -30 |
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| RHUMBLINE ADVISERS 0.00% of their portfolio | 87.7k $0 | Reduced -30 |
| Propel Bio Management, LLC 0.00% of their portfolio | 79.4k $2.5k | Unchanged |
| Sterling Capital Management LLC 0.00% of their portfolio | 1.0k $0 | Reduced -47 |
| ORG Partners LLC 0.00% of their portfolio | 30 $0 | Unchanged |